FELIX SALZBERG: Open Payments
NPI 1285709519 · HAMMONTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 20 payments from 7 companies in 2025. Trend: 2023 $46 · 2024 $275 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $110 |
| Vanda Pharmaceuticals Inc. | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Almatica Pharma LLC | 2 | $47 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: COBENFY, FANAPT, REXULTI, SPRAVATO, LOREEV XR, Auvelity, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
